PT2106808T - Agente de imagiologia de diagnóstico radioativo compreendendo ácido 1-amino-3-[18f]fluoro-ciclobutanocarboxílico - Google Patents

Agente de imagiologia de diagnóstico radioativo compreendendo ácido 1-amino-3-[18f]fluoro-ciclobutanocarboxílico

Info

Publication number
PT2106808T
PT2106808T PT78321742T PT07832174T PT2106808T PT 2106808 T PT2106808 T PT 2106808T PT 78321742 T PT78321742 T PT 78321742T PT 07832174 T PT07832174 T PT 07832174T PT 2106808 T PT2106808 T PT 2106808T
Authority
PT
Portugal
Prior art keywords
amino
imaging agent
diagnostic imaging
radioactive diagnostic
fluorocyclobutanecarboxylic acid
Prior art date
Application number
PT78321742T
Other languages
English (en)
Inventor
Hayashi Akio
Toyama Masahito
Kaneko Emi
Shinmura Toshiyuki
Nakamura Daisaku
Nakamura Soichi
Tokunaga Shinji
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of PT2106808T publication Critical patent/PT2106808T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
PT78321742T 2006-12-21 2007-11-20 Agente de imagiologia de diagnóstico radioativo compreendendo ácido 1-amino-3-[18f]fluoro-ciclobutanocarboxílico PT2106808T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006343753 2006-12-21

Publications (1)

Publication Number Publication Date
PT2106808T true PT2106808T (pt) 2018-03-26

Family

ID=39536156

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78321742T PT2106808T (pt) 2006-12-21 2007-11-20 Agente de imagiologia de diagnóstico radioativo compreendendo ácido 1-amino-3-[18f]fluoro-ciclobutanocarboxílico

Country Status (16)

Country Link
US (1) US8790620B2 (pt)
EP (1) EP2106808B1 (pt)
JP (1) JP5159636B2 (pt)
KR (2) KR101579796B1 (pt)
CN (1) CN101563107B (pt)
AU (1) AU2007335633A1 (pt)
BR (1) BRPI0721157A2 (pt)
CA (1) CA2672262C (pt)
ES (1) ES2663696T3 (pt)
HK (1) HK1134901A1 (pt)
NO (1) NO343137B1 (pt)
PL (1) PL2106808T3 (pt)
PT (1) PT2106808T (pt)
RU (1) RU2445120C2 (pt)
TW (1) TWI409083B (pt)
WO (1) WO2008075522A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063824A1 (ja) 2005-11-29 2007-06-07 Nihon Medi-Physics Co., Ltd. 放射性ハロゲン標識有機化合物の前駆体化合物
CA2678020C (en) * 2007-02-13 2015-03-24 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
AU2011351550B2 (en) 2010-12-29 2017-02-02 Ge Healthcare Limited Eluent solution
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
IN2014DN03245A (pt) * 2011-12-21 2015-07-10 Ge Healthcare Ltd
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2756593B2 (ja) 1989-09-01 1998-05-25 日本鋼管株式会社 地中掘削装置
JPH0443497A (ja) 1990-06-09 1992-02-13 Omron Corp 多車線対応型車両感知器
JPH0456725A (ja) 1990-06-26 1992-02-24 Sumitomo Metal Ind Ltd 加工性に優れた熱延鋼板の製造方法
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
CA2234633A1 (en) * 1995-10-17 1997-04-24 G.D. Searle & Co. Method of detecting cyclooxygenase-2
JP4242465B2 (ja) 1996-09-18 2009-03-25 日本メジフィジックス株式会社 放射線防護剤
US6027710A (en) 1996-09-18 2000-02-22 Nihon Medi-Physiscs Co., Ltd. Radiation-protecting agent
US6812327B1 (en) * 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US6017706A (en) 1997-05-07 2000-01-25 The United States Of America As Represented By The Department Of Health And Human Services Process for identifying compounds which protect against the formation of fluorescent light induced DNA lesions and x-ray-induced lesions
EP1365813A4 (en) * 2001-02-26 2006-03-22 Bristol Myers Squibb Pharma Co ASCORBIC ACID ANALOGUES FOR METALLORADIOPHARMACEUTICAL PRODUCTS
EP1356827A1 (en) * 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
ATE473019T1 (de) 2002-11-05 2010-07-15 Ion Beam Applic Sa Stabilisierung von wässerigen zusammensetzungen von 18f-markiertem 2-fluoro-2-deoxy-d-glukose mit ethanol
KR100508518B1 (ko) 2002-11-13 2005-08-17 한미약품 주식회사 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
GB0229695D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
GB0422004D0 (en) 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
DK1889834T3 (da) 2005-05-23 2011-08-08 Nihon Mediphysics Co Ltd Ny organisk forbindelse og fremgangsmåde til at fremstille radioaktiv halogenmærket organisk forbindelse ved anvendelse af samme
EP1893246A4 (en) * 2005-06-23 2009-05-06 Univ Emory STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGUE FOR TUMOR IMAGING
CA2678020C (en) * 2007-02-13 2015-03-24 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent

Also Published As

Publication number Publication date
CA2672262C (en) 2016-07-05
WO2008075522A1 (ja) 2008-06-26
JPWO2008075522A1 (ja) 2010-04-08
TWI409083B (zh) 2013-09-21
EP2106808A4 (en) 2013-02-27
CA2672262A1 (en) 2008-06-26
AU2007335633A1 (en) 2008-06-26
KR20150004940A (ko) 2015-01-13
NO20092382L (no) 2009-09-16
KR20090094081A (ko) 2009-09-03
US20100028258A1 (en) 2010-02-04
BRPI0721157A2 (pt) 2014-04-01
CN101563107A (zh) 2009-10-21
CN101563107B (zh) 2012-07-11
HK1134901A1 (en) 2010-05-20
EP2106808B1 (en) 2018-02-21
NO343137B1 (no) 2018-11-19
EP2106808A1 (en) 2009-10-07
PL2106808T3 (pl) 2018-07-31
KR101579796B1 (ko) 2015-12-24
RU2445120C2 (ru) 2012-03-20
US8790620B2 (en) 2014-07-29
ES2663696T3 (es) 2018-04-16
JP5159636B2 (ja) 2013-03-06
RU2009128055A (ru) 2011-01-27
TW200826964A (en) 2008-07-01
KR101497406B1 (ko) 2015-03-02

Similar Documents

Publication Publication Date Title
PL1973466T3 (pl) Balonowy cewnik do obrazowania
IL193737A0 (en) Artery imaging system
EP1992271A4 (en) CAPSULE ENDOSCOPIC SYSTEM
EP2063783A4 (en) COMPLEX DENTAL IMAGING SYSTEM
IL211526A0 (en) Compounds and methods for 18f labeled agents, compositions comprising such compounds and their use for diagnostic imaging
EP1983926A4 (en) ENDOSCOPE WITH IMAGES CAPSULE
EP2178442A4 (en) CATHETER FOR IMAGING IN-VIVO
EP2026738A4 (en) PATIENT AUSCULTATION SYSTEM
EP2085032A4 (en) GENERAL IMAGING SYSTEM
GB0602380D0 (en) Imaging system
EP1996078A4 (en) PICTURE SYSTEM
EP2004809A4 (en) EX VIVO CREATED TISSUE SYSTEM
EP2037814A4 (en) ULTRASONIC 3D IMAGING SYSTEM
EP1980207A4 (en) RADIOGRAPHIC IMAGER
GB0716885D0 (en) Diagnostic agent
PL2106808T3 (pl) Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy
IL187945A (en) Medical Imaging Systems
EP1797903A4 (en) DIAGNOSTIC AGENT FOR TUMOR
EP1862118A4 (en) RADIOGRAPHIC IMAGING SYSTEM
EP2277447A4 (en) MEDICAL X-RAY GENERATOR
HK1106125A1 (en) Imaging system
EP2211696A4 (en) INTRA-ORAL THREE DIMENSIONAL IMAGING SYSTEM
EP1974674A4 (en) PICTURE SYSTEM
EP2063784A4 (en) MEDICAL X-RAY DEVICE
EP2269514A4 (en) X-RAY IMAGING SYSTEM FOR MEDICAL USE